Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization.
Genes, Brain and Behavior 12 (8): 780-791.
Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions.
Epigenomics 5 (4): 367-377.
Genes, environments, and developmental research: Methods for a multi-site study of early substance abuse.
Twin Research and Human Genetics 16 (2): 505-515.
A comprehensive family-based replication study of schizophrenia genes.
JAMA Psychiatry 70 (6): 573-581.
Estimation of CpG coverage in whole methylome next-generation sequencing studies.
BMC Bioinformatics 14 (1): 50.
Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure.
Metabolomics 9 (2): 392-402.
Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*D.
PLoS ONE 8 (2): e55239.
Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
Pharmacogenetics and Genomics 23 (2): 69-77.